ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Part of PAION AG, Paion UK Ltd. is a company headquartered in Cambridge, UK. The firm develops and supplies sedation and anesthesia products. It was founded in 1995.

Pharmasol Ltd., a subsidiary of OBG Pharmaceuticals Ltd., is a company headquartered in Liverpool, UK, that manufactures contract filler of small aerosols and pumps for pharmaceutical. The firm was founded in 1973. Bioglan Pharma Plc acquired Pharmasol Ltd. on September 01, 1997.\nThe company says this about itself: The principal activity of the company continued to be that of manufacture and distribution of over the counter products.

Takeda Pharma AS develops, manufactures and distributes pharmaceutical products. The company is headquartered in Estonia.

HEXAL is the German generic manufacturer and belongs to the worldwide Sandoz Group with its headquarters in Holzkirchen, Bavaria. HEXAL brings biosimilars to the German market. Biosimilars are high-differentiated products, based on very complex biological molecules. Biologics, or biopharmaceuticals, are medicines produced from living organisms using biotechnology techniques. Many biologics are recombinant proteins and are manufactured using „recombinant DNA“ technology, a process that involves inserting a specific gene into a host cell to produce a particular protein. These complex state-of-the-art molecules represent a distinct regulatory class of medicine compared to traditional, chemically synthesized medicines. In Germany HEXAL employs more then 4.000 people at six sites. The company was founded in 1986 and merged with Sandoz in 2006.

Acino AG engages in the development and manufacture of pharmaceutical products. It also offers services such as registration, procurement, contract manufacturing, packaging, and logistics. Its products include solid oral dosage forms, patches, as well as biodegradable and subcutaneous implants. The company was founded by Wilfried Fischer in 1997 and is headquartered in Miesbach, Germany.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap. The company was founded in 1995 and their first product Diabact UBT, a breath test for diagnosing the causative agent of stomach ulcers (Helicobacter pylori), was introduced in 2000. In 2003, the company adopted the name Orexo and in 2005 the company was listed on the Stockholm Stock Exchange.On March 29, 2019 a U.S. jury rejected a claim by Sweden’s Orexo AB that two generic opioid-addiction treatments created by Teva Pharmaceutical Industries Ltd. infringed a patent for Orexo’s biggest drug, Zubsolv.

Panjin Green Kammer Technology Co., Ltd., established on 2015-08-07, Business scope includes technology development,Technology Promotion,technology transfer,Technical Services;Sales of self-developed products;Equipment,Chemical Products(Does not contain flammable, explosive and dangerous chemicals)Production,Sales;Import and export,Technology Import and Export,Import and export agency;Economic and Trade Consulting,Investment Advisory,Business Management Consulting;business management;market survey;Hazardous Chemical Sales(according to<Hazardous Chemical Business License>License scope and validity period to operate,Handle hazardous chemicals without storage facilities).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

INSYS Therapeutics, Inc. operates as a pharmaceutical company, which develops and commercializes supportive care products. It focuses on utilizing commercial pharmaceutical products that include Subsys, a proprietary sublingual fentanyl spray for BTCP in opioid-tolerant adult patients; and Syndros, a proprietary orally administered liquid formulation of dronabinol for the treatment of CINV and anorexia associated with weight loss in patients with AIDS. The company was founded by John N. Kapoor on June 15, 1990 and is headquartered in Chandler, AZ.

BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine. They are utilizing their novel and proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology to develop and commercialize, either on their own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.

TerSera Therapeutics LLC develops pharmaceutical products. Its therapeutic areas include allergy or immunology, CNS disorders, endocrinology, gastroenterology, infectious disease, oncology, orphan diseases, rheumatology, transplant-related therapies, urology, and women's health. The company was founded by Edward J. Fiorentino in 2016 and is headquartered in Lake Forest, IL.

Luye Pharma AG provides a wide variety of services to pharmaceutical suppliers at every stage of the value chain. This includes everything from the acquisition of active components to the long-term management of end-product life cycles. They provide carefree license models for their own products in addition to collaborations with pharmaceutical businesses in the fields of research, development, and the cost-effective production of complicated pharmaceuticals.

Troikaa Pharmaceuticals Ltd. is an Indian private company located in Ahmedabad. The firm manufactures and supplies pharmaceutical products. It was founded in 1994.

It is a biopharmaceutical company that researches and develops advanced new type pharmaceuticals / cosmetics . Drug delivery systems that they intensively research and develop are transdermal delivery formulations Patient-friendly administration through the route of administration and formulation modification of existing oral agents It is a patch formulation. They have world-class skin permeation enhancement technology, various patch structure design technology, They supply products to domestic and overseas partners based on drug release control technology and manufacturing process technology. They have world-class skin permeation enhancement technology, various patch structure designing technology, drug release control technology and manufacturing process technology based on innovative research and development aiming first-in-class. Pharmaceutical KGMP production facility, after strict process control and quality inspection, produce medicinal products and supply products to domestic and overseas partners. ICEQUE Co., Ltd. is committed to the improvement of quality of life through the development of new drugs They are doing their best to grow into a global company.